| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| I1HYJ4 | Uncharacterized protein; | BRADI3G07617; | NULL | 412 | bromus |
| I1I536 | Uncharacterized protein; | BRADI3G29975; | NULL | 217 | bromus |
| I1GKS6 | Uncharacterized protein; | BRADI1G01430; | XP_003559130.1; | 125 | bromus |
| I1I4G6 | Uncharacterized protein; | BRADI3G28040; | XP_003571846.1; | 563 | bromus |
| I1HYF5 | Uncharacterized protein; | BRADI3G07315; | NULL | 407 | bromus |
| I1I4R7 | Uncharacterized protein; | BRADI3G28937; | NULL | 711 | bromus |
| I1I7I7 | Uncharacterized protein; | BRADI3G37260; | XP_003572250.1; | 657 | bromus |
| I1I930 | S-acyltransferase; EC 2.3.1.225; Palmitoyltransferase; | BRADI3G41670; | XP_003574851.1; | 423 | bromus |
| I1HSP1 | Uncharacterized protein; | BRADI2G52977; | NULL | 351 | bromus |
| I1HJK1 | Uncharacterized protein; | BRADI2G25800; | XP_003568495.1; | 236 | bromus |
| I1HWS1 | Phosphatidate cytidylyltransferase; EC 2.7.7.41; | BRADI3G02640; | XP_003573892.1; | 361 | bromus |
| I1I3H2 | V-type proton ATPase subunit a; | BRADI3G22870; | XP_003573831.1; | 823 | bromus |
| I1GX70 | Uncharacterized protein; | BRADI1G35690; | XP_003563596.1; | 191 | bromus |
| I1I557 | Uncharacterized protein; | BRADI3G30127; | NULL | 332 | bromus |
| I1I1Q8 | Uncharacterized protein; | BRADI3G17370; | NULL | 127 | bromus |
| I1IIP0 | Uncharacterized protein; | BRADI4G08080; | XP_003576651.1; | 654 | bromus |
| I1HKU2 | Uncharacterized protein; | BRADI2G31910; | XP_003568727.1; | 688 | bromus |
| I1GL49 | Uncharacterized protein; | BRADI1G02490; | XP_003562862.1; | 557 | bromus |
| I1ICM9 | Uncharacterized protein; | BRADI3G51800; | XP_003570107.1; | 261 | bromus |
| I1I1K5 | Uncharacterized protein; | BRADI3G16990; | XP_003573495.1; | 602 | bromus |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |